137 results on '"Schwartz, Peter J"'
Search Results
2. Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome
3. Blocking nerves and saving lives: Left stellate ganglion block for electrical storms
4. Continuous Bayesian variant interpretation accounts for incomplete penetrance among Mendelian cardiac channelopathies
5. COVID-19 vaccination in patients with long QT syndrome
6. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology
7. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases
8. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management
9. Harmonization of the definition of sudden cardiac death in longitudinal cohorts of the European Sudden Cardiac Arrest network – towards Prevention, Education, and New Effective Treatments (ESCAPE-NET) consortium
10. Remote Monitoring of the QT Interval and Emerging Indications for Arrhythmia Prevention
11. Genotype Predicts Outcomes in Fetuses and Neonates With Severe Congenital Long QT Syndrome
12. Use of hiPSC-derived cardiomyocytes to study LQTS-variant specific proarrhythmic effects of drugs
13. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome
14. Determinants of occurrence and survival after sudden cardiac arrest–A European perspective: The ESCAPE-NET project
15. Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk?
16. The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?
17. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation
18. Channelopathies as Causes of Sudden Cardiac Death
19. Rationale and design of a prospective study to assess the effect of left cardiac sympathetic denervation in chronic heart failure
20. Regional Lack of Consistency in the Management of Atrial Fibrillation (from the RECORD-AF Trial)
21. Autonomic Control of Heart Rate and QT Interval Variability Influences Arrhythmic Risk in Long QT Syndrome Type 1
22. The Role of the Cardiac Sodium Channel in Perinatal Early Infant Mortality
23. Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19
24. Impact of Genetics on the Clinical Management of Channelopathies
25. The Role of the Sympathetic Nervous System in the Long QT Syndrome: The Long Road from Pathophysiology to Therapy
26. 96 - Long and Short QT Syndromes
27. PO-02-163 IMPLANTABLE LOOP RECORDERS IN PATIENTS WITH BRUGADA SYNDROME: THE BRULOOP STUDY
28. PO-02-089 AN EXAMINATION OF GUIDELINE-DIRECTED DEVICE THERAPY WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR FOR LONG QT SYNDROME
29. PO-02-087 NEW IDENTIFIER OF ARRHYTHMIA RISK IN PATIENTS WITH CONGENITAL LONG-QT SYNDROME
30. PO-01-077 IDENTIFYING NOVEL DISEASE MODIFIERS IN PATIENTS WITH CONGENITAL LONG QT SYNDROME
31. BS-469619-003 GRANULAR VARIANT-SPECIFIC FEATURES IMPROVE KCNH2-LONG QT SYNDROME RISK STRATIFICATION
32. CE-482905-003 EFFICACY OF MEXILETINE FOR LQT2: EVIDENCE FROM HIPSC-DERIVED CARDIOMYOCYTES, TRANSGENIC RABBITS AND PATIENTS
33. Real-Life Observations of Clinical Outcomes With Rhythm- and Rate-Control Therapies for Atrial Fibrillation: RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation)
34. High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study
35. Inherited Cardiac Arrhythmia Syndrome: Role of Potassium Channels
36. Top stories on congenital long QT syndrome
37. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: The surgical supraclavicular approach to cervicothoracic sympathectomy
38. The RecordAF Study: Design, Baseline Data, and Profile of Patients According to Chosen Treatment Strategy for Atrial Fibrillation
39. Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome
40. Vagal stimulation for heart failure: Background and first in-man study
41. Of founder populations, long QT syndrome, and destiny
42. A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome
43. All LQT3 patients need an ICD: True or false?
44. Neural Control of Heart Rate Is an Arrhythmia Risk Modifier in Long QT Syndrome
45. Prediction of unexpected sudden death among healthy dogs by a novel marker of autonomic neural activity
46. Risk of death in the long QT syndrome when a sibling has died
47. Baroreflex Sensitivity Predicts Long-Term Cardiovascular Mortality After Myocardial Infarction Even in Patients With Preserved Left Ventricular Function
48. Long QT Syndrome and Pregnancy
49. Long QT Syndrome in Adults
50. EN-452414-5 VENTRICULAR CONDUCTION IS A MARKER FOR ARRHYTHMIC RISK IN OVERLAP SODIUM CHANNEL DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.